Effect of intravenous gamma globulin on short- and mid-term clinical outcome in acute viral myocarditis in children - World Journal of Cardiovascular Diseases

WJCD > Vol.4 No.2, February 2014

World Journal of Cardiovascular Diseases

Volume 4, Issue 2 (February 2014)

ISSN Print: 2164-5329 ISSN Online: 2164-5337

Google-based Impact Factor: 0.38 Citations

Effect of intravenous gamma globulin on short- and mid-term clinical outcome in acute viral myocarditis in children ()

HTML

Download as PDF (Size: 148KB) PP. 39-44

DOI: 10.4236/wjcd.2014.42007 3,848 Downloads 5,703 Views Citations

Author(s)

Mehnaz Atiq, Mehar Hoda, Nadeem Aslam

Affiliation(s)

Section of Pediatric Cardiology, Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi, Pakistan.

ABSTRACT

Acute viral myocarditis is an extremely diverse disease with a predictable good outcome with supportive therapy. The objective of this study was to look at the clinical outcome of patients receiving additional intravenous gamma globulin compared to those receiving conventional anti-congestive therapy alone. Patients and methods: This is a retrospective review of charts of children admitted with acute myocarditis. Group 1 was children who received intravenous gamma globulin (IVIG) along with conventional anti-congestive therapy. Group 2 were patients who received the conventional anticongestive therapy alone. Short-term outcome was survival to hospital discharge, and mid-term outcome was improvement of left ventricular ejection fraction at 6 months and one year follow-up. Results: A total of 36 patients were enrolled and 18 were males. The mean age of all patients was 2.3 ± 2.6 years and the mean duration of illness for the whole group was 6.7 ± 3.8 days. Group 1 comprised of 16 patients. There was no difference in short-term outcome with mortality of 2 patients in Group1 (12.5%) and 3(15%) in Group 2 (p = 0.2). At intermediate term follow up, recovery of ejection fraction in Group 1 was in 4/14 (28%) and in Group 2 it was 9/17 (55%) and at 12 months it was 10/13 (77%) in Group 1 and 15/16 (94%) in Group 2 (p = 0.02 and 0.19 respectively). Conclusion: Acute myocarditis has a high spontaneous cure rate. Our study did not show any significant difference in the short-term or midterm outcome between children receiving IVIG compared to those who did not.

KEYWORDS

Acute Myocarditis; Intravenous Gamma Globulins; Congestive Heart failure

Share and Cite:

Atiq, M. , Hoda, M. and Aslam, N. (2014) Effect of intravenous gamma globulin on short- and mid-term clinical outcome in acute viral myocarditis in children. World Journal of Cardiovascular Diseases, 4, 39-44. doi: 10.4236/wjcd.2014.42007.

Cited by

[1]	A Systematic Review Incorporating Meta-Analysis on the Effectiveness of Intravenous Immunoglobulin Versus Corticosteroids in the Treatment of Pediatric Myocarditis
	Journal of Clinical and Nursing …, 2022

[2]	Effect of gamma globulin combined with creatine phosphate on viral myocarditis
	2021

[3]	Intravenous Immunoglobulin Therapy in Myocarditis
	2020

[4]	In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy
	2019

[5]	Intravenous Immunoglobulin Therapy for Acute Myocarditis in Children and Adults
	2019

[6]	Corticosteroids and intravenous immunoglobulin in pediatric myocarditis: a meta-analysis
	2019

[7]	Intravenous immunoglobulin therapy for acute myocarditis in children and adults a meta-analysis
	2019

[8]	Miocardita acută virală la copil Protocol clinic naţional
	2018

[9]	Miocardita acută virală la copil: protocol clinic naţional PCN-145
	2018

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies